SPONSORED CONTENT
 
EQ Spotlight  
Gold Broke $5,000. Now What?
Analysts are debating whether this marks the beginning of a larger repricing.
Learn More
RTX Shares Pop on a Strong Quarter

 
2 Minute Read • Posted Jan 28, 2026
 
 
  RTX
-0.4370%

RTX Corporation

RTX showed up to the Q4 conference call on January 27, 2026 with numbers investors actually clap for. Sales were reported at about $24.2 billion (+12% YoY) and adjusted EPS of $1.55, both ahead of what analysts were looking for, with consensus around $22.7B sales and $1.47 EPS. The market responded with a polite standing ovation — shares were up roughly 3–4% in early trading after the report.

The best part is that this wasn’t just one division doing all the heavy lifting. This performance is tied to aircraft engine demand and commercial maintenance, with Pratt & Whitney and services demand helping drive the quarter, while Collins and Raytheon also posted growth. So RTX didn’t win the quarter with a single lucky punch — it looked more like a disciplined, multi-round scorecard.

Then RTX talked about next year. Management guided 2026 adjusted sales of $92–$93 billion and adjusted EPS of $6.60–$6.80, with commentary pointing to ~5–6% organic sales growth. The company also pointed to a $268 billion backlog of commercial and defense contracts, which is basically a very large, legally binding “to-do list” that the Pentagon and global aviation refuse to stop adding to.

For the capital-returns crowd, RTX also noted it paid $3.57 billion in dividends in 2025 (up 11% from 2024), and plans to invest $500 million in munitions production facilities in 2026 — a signal that demand isn’t just strong on paper, they’re spending to meet it. RTX is pairing commercial aerospace momentum with defense demand visibility, and the 2026 outlook suggests the company thinks that combo still has runway.
SPONSORED CONTENT
Because you've previously shown interest in Gold: We Found A Gold Offer That You Might Be Interested In!
By clicking the ad above, you will be directed to Microsectors.com (Privacy Policy).
Disclaimer: This content is for informational and entertainment purposes only and does not constitute financial or investment advice. The information provided may be outdated or contain inaccuracies. Always conduct your own due diligence and consult a licensed financial advisor before making investment decisions. Investing involves risk, including the potential loss of principal. Unless explicitly stated otherwise, neither Equiscreen, LLC nor its beneficial owners hold any financial interest in the companies mentioned in our articles, and we do not receive compensation for including them. Equiscreen, LLC and its beneficial owners may buy or sell securities of any company referenced in our content at any time and without prior notice, and nothing published by Equiscreen, LLC should be interpreted as a recommendation to buy, sell, or hold any security. Any paid content or income-related materials will be clearly identified as “Sponsored” or “Advertorial,” and corresponding income disclosures can be found at the bottom of the page. For additional information, please contact [email protected].
Top Gainers  
Name / Symbol Price Change
 
  SDOT
$25.30
77.54%
 
  ODVWZ
$0.0869
72.76%
 
  SLND
$1.14
67.33%
 
  CJMB
$1.22
41.70%
 
  BIYA
$4.14
36.18%
* Financial Data Delayed


Top Losers  
Name / Symbol Price Change
 
  VIVK
$2.26
-46.95%
 
  NIXXW
$0.0024
-46.67%
 
  STAK
$1.92
-46.37%
 
  BURU
$0.0727
-39.21%
 
  QMLS
$14.28
-33.36%
* Financial Data Delayed


U.S. Commodities  
Name / Symbol Year High Year Low Last Price
Gold Futures 5626.8 3300 $4018.8
0.66882%
Silver Futures 121.3 36.345 $56.326
0.24739%
Brent Crude Oil 119.4 58.72 $88.1
4.59456%
* Financial Data Delayed


 
Elevance Health’s Quarter Outruns Its Forecast
2 Minute Read
 
Goldman Sachs Cashes In On A Chaotic Quarter
2 Minute Read
 
Tower Semiconductor Turns Grants Into Growth
2 Minute Read
 
AppLovin’s E-Commerce Rollout Spooks Investors
2 Minute Read
Trading Ideas

 
5 Green Stocks That Are Actually Profitable
4 Minute Read
Learn

 
Home Buying 101: Market Analysis
Real Estate
 
Asset Allocation Models
Asset Allocation
 
Mutual Fund Ratings
Mutual Funds
 
Tax Implications Across Investments
Tax Planning
 
Introduction To Bonds
Bonds


2234 N Federal Hwy # 1022
Boca Raton, FL 33431


(561) 264-5726
Equiscreen
About EQ Editorial Policy Contact Us Corrections Policy
What's Trending
Articles Top Gainers
Explore More
Stocks By Sector Market Screener Financial Calendar Market Holidays
Additional Information
Disclaimer Privacy Policy Do Not Sell My Information Sitemap